MCP Server For Financial Data by EODHD Learn more

Marker Therapeutics, Inc. (GX1 F) stock market data APIs

€1.3766 0(0%)
as of January 16, 2026
Try our APIs with free plan!

Marker Therapeutics, Inc. Financial Data Overview

Price chart is built with Anychart

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Prev. Close 1.3766
Open 1.3766
High 1.3766
Low 1.3766
52 wk Range 0.575-2.24
Market Cap 19 508 K
Shares Outstanding 16 673 K
Revenue 4 695 K
Beta 1.372

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Marker Therapeutics, Inc. (top by weight)

Ticker
100-day Price Change
Weight
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
20.96 (6.53%)
0.00
VXF.US Vanguard Extended Market Index Fund ETF Shares
16.9 (8.28%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Marker Therapeutics, Inc. data using free add-ons & libraries


Get Marker Therapeutics, Inc. Fundamental Data

Marker Therapeutics, Inc. Fundamental data includes:

  • Net Revenue: 4 695 K
  • EBITDA:
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Marker Therapeutics, Inc. Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: NaN
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Marker Therapeutics, Inc. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.